#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Eduardo Munoz Email
Chief Scientific Officer . Emerald Health Pharmaceuticals
How to contact Eduardo Munoz
Join and see Eduardo's contact info for free!Current Roles
Employees:
21Revenue:
$3.3MAbout
Emerald Heath Pharmaceuticals is a biotech company developing medicines based on first-in-class cannabinoid science and technology to treat diseases with significant unmet medical needs, including multiple sclerosis, systemic sclerosis (a form of scleroderma), Parkinson's disease and Huntington's disease. Any statements regarding Emerald Health Pharmaceuticals' Regulation A+ financing shall not be deemed an offer to buy or offer to sell securities. Offers will be made only to qualified investors who have reviewed the Company’s offering circular. View here: https://investehp.com/wp-content/uploads/2019/07/Supplement-No.-2-merged-with-Supplement-Final-OC.pdf. References/Sources: - National Multiple Sclerosis Society - Parkinson’s Foundation - Huntington’s Disease Society of America - Scleroderma Foundation - Global Multiple Sclerosis Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 To 2025 Research and Markets Report - Scleroderma Diagnostics and Therapeutics Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2024 Transparency Market Research Report - Parkinson's Disease Therapeutics Market Global Industry Analysis Size, Share, Growth ,Trends, and Forecasts, 2017 To 2025 Transparency Market Research Report - Opportunity Analyzer: Huntington's Disease Opportunity Analysis and Forecast to 2024 Research and Markets ReportEmerald Health Pharmaceuticals Address
Sorrento Valley RdSan Diego, CA